Channel Therapeutics Corporation - CHRO

About Gravity Analytica
Recent News
- 11.04.2025 - Pete Blackhurst, International SaaS Revenue Leader, Joins VisitIQ™ as Chief Revenue Officer
- 09.24.2025 - Upcoming Webcast: Targeting 2.0 – Using AI to Build Better Audiences
- 09.17.2025 - Smarter ICPs Start Here: How Agencies Use AI to Unlock Real Results
- 09.16.2025 - Lookalike Audiences That Work: Why AI Gives Agencies an Unfair Advantage
- 09.08.2025 - Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
- 09.02.2025 - Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference
- 08.18.2025 - Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
Recent Filings
- 10.14.2025 - 8-K Current report
- 10.14.2025 - EX-99.1 EX-99.1
- 09.29.2025 - 424B3 Prospectus [Rule 424(b)(3)]
- 09.24.2025 - EFFECT Notice of Effectiveness
- 09.19.2025 - S-3/A Registration statement under Securities Act of 1933
- 09.16.2025 - 8-K/A Current report
- 09.03.2025 - EX-99.1 EX-99.1
- 09.03.2025 - 8-K Current report
- 08.28.2025 - S-3 Registration statement under Securities Act of 1933
- 08.18.2025 - 8-K Current report